HC Wainwright Reiterates Buy Rating on Syndax Pharmaceuticals, Keeps $38 Target
HC Wainwright reiterated its Buy rating and $38.00 price target on Syndax Pharmaceuticals. The target implies 129.6% upside from the October 12 close of $16.55.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.